Paradigm Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Paradigm Asset Management's CRL Position: Q2 2026 in Review
Paradigm Asset Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 176 shares worth $39.9K. The position accounts for 0.01% of the portfolio, ranked #387.
Paradigm Asset Management first reported a position in CRL in Q4 2015 and has held it in 26 quarters since. The position peaked at $1.07M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Paradigm Asset Management held 176 shares of Charles River Laboratories worth $39.9K as of Q2 2026.
- Paradigm Asset Management left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up 0.01% of Paradigm Asset Management's portfolio in Q2 2026, its #387 holding.
- Paradigm Asset Management first reported a position in Charles River Laboratories in Q4 2015 and has held it in 26 quarters since.
- Paradigm Asset Management's Charles River Laboratories position peaked at $1.07M in Q3 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Paradigm Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.